BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 15921802)

  • 1. The effects of long-term beta-blockade on the ventilatory responses to exercise in chronic heart failure.
    Witte KK; Thackray S; Nikitin NP; Cleland JG; Clark AL
    Eur J Heart Fail; 2005 Jun; 7(4):612-7. PubMed ID: 15921802
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of beta-blockers on ventilation efficiency in heart failure.
    Agostoni P; Apostolo A; Cattadori G; Salvioni E; Berna G; Antonioli L; Vignati C; Schina M; Sciomer S; Bussotti M; Palermo P; Fiorentini C; Contini M
    Am Heart J; 2010 Jun; 159(6):1067-73. PubMed ID: 20569721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A failed improvement in pulmonary function and exercise capacity with carvedilol in congestive heart failure despite an excellent effect on left ventricular function].
    Guazzi M; Pontone G; Trevisi N; Lomanto M; Matturri M; Agostoni P
    Cardiologia; 1998 Feb; 43(2):181-7. PubMed ID: 9557374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lung function with carvedilol and bisoprolol in chronic heart failure: is beta selectivity relevant?
    Agostoni P; Contini M; Cattadori G; Apostolo A; Sciomer S; Bussotti M; Palermo P; Fiorentini C
    Eur J Heart Fail; 2007 Aug; 9(8):827-33. PubMed ID: 17561440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differences between bisoprolol and carvedilol in patients with chronic heart failure and chronic obstructive pulmonary disease: a randomized trial.
    Lainscak M; Podbregar M; Kovacic D; Rozman J; von Haehling S
    Respir Med; 2011 Oct; 105 Suppl 1():S44-9. PubMed ID: 22015086
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of β-blocker cessation on chronotropic incompetence and exercise tolerance in patients with advanced heart failure.
    Hirsh BJ; Mignatti A; Garan AR; Uriel N; Colombo P; Sims DB; Jorde UP
    Circ Heart Fail; 2012 Sep; 5(5):560-5. PubMed ID: 22855557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beta-blockers and inspiratory pulmonary function in chronic heart failure.
    Witte KK; Clark AL
    J Card Fail; 2005 Mar; 11(2):112-6. PubMed ID: 15732030
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pulmonary function, cardiac function, and exercise capacity in a follow-up of patients with congestive heart failure treated with carvedilol.
    Guazzi M; Agostoni P; Matturri M; Pontone G; Guazzi MD
    Am Heart J; 1999 Sep; 138(3 Pt 1):460-7. PubMed ID: 10467196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of alpha and beta blockade on ventilatory responses to exercise in chronic heart failure.
    Witte KK; Thackray SD; Nikitin NP; Cleland JG; Clark AL
    Heart; 2003 Oct; 89(10):1169-73. PubMed ID: 12975409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of exercise ventilation in clinical evaluation and risk stratification in patients with chronic heart failure.
    Jankowska EA; Pietruk-Kowalczyk J; Zymliński R; Witkowski T; Ponikowska B; Sebzda T; Rzeczuch K; Borodulin-Nadzieja L; Hańczycowa H; Banasiak W; Ponikowski P
    Kardiol Pol; 2003 Aug; 59(8):115-27; commentary 126-7. PubMed ID: 14560326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of beta-blocker therapy on ventilatory responses to exercise in patients with heart failure.
    Wolk R; Johnson BD; Somers VK; Allison TG; Squires RW; Gau GT; Olson LJ
    J Card Fail; 2005 Jun; 11(5):333-9. PubMed ID: 15948082
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronotropic incompentence and functional capacity in chronic heart failure: no role of β-blockers and β-blocker dose.
    Magrì D; Palermo P; Cauti FM; Contini M; Farina S; Cattadori G; Apostolo A; Salvioni E; Magini A; Vignati C; Alimento M; Sciomer S; Bussotti M; Agostoni P
    Cardiovasc Ther; 2012 Apr; 30(2):100-8. PubMed ID: 20553283
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carvedilol improves left ventricular function and symptoms in chronic heart failure: a double-blind randomized study.
    Olsen SL; Gilbert EM; Renlund DG; Taylor DO; Yanowitz FD; Bristow MR
    J Am Coll Cardiol; 1995 May; 25(6):1225-31. PubMed ID: 7722114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of bisoprolol fumarate on left ventricular size, function, and exercise capacity in patients with heart failure: analysis with magnetic resonance myocardial tagging.
    Dubach P; Myers J; Bonetti P; Schertler T; Froelicher V; Wagner D; Scheidegger M; Stuber M; Luchinger R; Schwitter J; Hess O
    Am Heart J; 2002 Apr; 143(4):676-83. PubMed ID: 11923805
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of carvedilol on left ventricular diastolic function and chamber volumes in advanced heart failure.
    Palazzuoli A; Quatrini I; Vecchiato L; Scali C; De Paola V; Iovine F; Martini G; Nuti R
    Minerva Cardioangiol; 2005 Aug; 53(4):321-8. PubMed ID: 16177676
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Acetylsalicylic acid antagonism vs ACE inhibitor in congestive heart failure as shown by a diminished respiratory and exercise capacity].
    Guazzi M; Lauri G; Melzi G; Cattadori G; Agostoni P
    Cardiologia; 1996 Jun; 41(6):527-33. PubMed ID: 8766415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Concentration of BNP, endothelin 1, pro-inflammatory cytokines (TNF-alpha, IL-6) and exercise capacity in patients with heart failure treated with carvedilol.
    Nessler J; Nessler B; Kitliński M; Gackowski A; Piwowarska W; Stepniewski M
    Kardiol Pol; 2008 Feb; 66(2):144-51; discussion 152-3. PubMed ID: 18344152
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beta blockers therapy is associated with improved left ventricular systolic function and sustained exercise capacity in elderly patients with heart failure. CIBIS-ELD sub-study.
    Dekleva M; Düngen HD; Gelbrich G; Incrot S; Suzic Lazic J; Pavlovic Kleut M; Tahirovic E; Waagstein F
    Aging Clin Exp Res; 2012 Dec; 24(6):675-81. PubMed ID: 23147689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Assessment of the efficacy of bisoprolol administration by cardiopulmonary exercise testing in patients with heart failure].
    Terzi S; Dayi SU; Akbulut T; Dağ O; Köse H; Satiroğlu O; Sayar N; Bilsel T; Aksoy S; Yeşilçimen K
    Anadolu Kardiyol Derg; 2003 Dec; 3(4):313-8. PubMed ID: 14675880
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of beta-adrenergic receptor gene polymorphisms in the long-term effects of beta-blockade with carvedilol in patients with chronic heart failure.
    Metra M; Covolo L; Pezzali N; Zacà V; Bugatti S; Lombardi C; Bettari L; Romeo A; Gelatti U; Giubbini R; Donato F; Dei Cas L
    Cardiovasc Drugs Ther; 2010 Feb; 24(1):49-60. PubMed ID: 20352314
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.